Clinical trial Recruiting at 1 site Interventional Ages 5 to 12

Ultrasound Visual Feedback for Young Children with Speech Apraxia

Official title: Feasibility and Preliminary Effects of a Therapeutic Approach Using Ultrasound Visual Biofeedback in Children With AFI: a Pilot Randomized Clinical Trial.

Run by Santa Catarina Federal University · NCT07087249 · Data updated 2026-11-12

This pilot study tests whether using real-time ultrasound tongue imaging during therapy helps children with Childhood Apraxia of Speech improve articulation more than usual care.

Quick facts

Study typeInterventional
Ages5 Years to 12 Years
SexAll
Enrollment20 (estimated)
SponsorSanta Catarina Federal University
Academic / other
Locations1 site (Florianópolis, Santa Catarina)
StatusRecruiting
StartedApril 1, 2026
Main results expectedOctober 1, 2027
Study endsJanuary 20, 2028
Registry record updatedOctober 27, 2026
Trial IDNCT07087249 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are monolingual Brazilian Portuguese-speaking children aged 5–12 with a confirmed CAS diagnosis and normal hearing, cognition, and receptive language.

Probably not a fit

Children with hearing loss, other neurological or anatomical conditions affecting speech, or bilingual exposure at home may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a small randomized pilot trial in children with CAS to see if adding ultrasound visual biofeedback to therapy is feasible and whether it shows promising signals of benefit. Participants aged 5–12 will be assigned to ultrasound-assisted therapy or a waitlist control for six weeks, with assessments before, after, and one month later. The study uses both quantitative measures and qualitative feedback to gauge feasibility, treatment fidelity, and potential effects on articulatory precision, prosody, and speech motor planning. Ultrasound imaging provides real-time visualization of tongue movements to guide practice with target sounds. Data will inform parameters for a larger, definitive trial if feasible.

Why it matters

Potential benefit: If successful, this approach could help children learn tongue placements more accurately, potentially improving speech clarity.

How similar studies have gone: Previous research in other populations has shown ultrasound biofeedback can aid speech motor learning, but evidence in CAS remains early and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

Clinical diagnosis of Childhood Apraxia of Speech (CAS) confirmed by assessment; Age between 5 and 12 years; Monolingual speakers of Brazilian Portuguese; Normal auditory, cognitive, and receptive language skills; Normal results on orofacial screenings.

Exclusion criteria:

Hearing impairment or auditory processing disorders; Neurological, intellectual, or anatomical conditions affecting speech (e.g., cleft palate, cerebral palsy, dysarthria); Diagnosis of global motor development disorders; Bilingual speakers or individuals exposed to other languages at home.

Where it's running

  • Prof. Dr. Aline Mara de Oliveira
    Florianópolis, Santa Catarina, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.